Phase 3 Trials of MDMA-Assisted Therapy for PTSD May 2021 Update: Seeking Research Volunteers

We are currently seeking research volunteers for our second Phase 3 clinical trial of MDMA-assisted therapy for PTSD. Volunteers will help contribute to scientific knowledge and will help us better understand if MDMA-assisted therapy works for treatment of PTSD. MAPS conducts clinical trials under the guidance and regulations of the U.S. Food and Drug Administration (FDA) in collaboration with federal regulators, including the Drug Enforcement Administration (DEA). To learn more about our clinical trials or apply to be a study participant, visit our website.

We are recruiting participants in the following locations: 

  • Los Angeles, California, United States
  • San Francisco, California, United States (Private Practice)
  • San Francisco, California, United States (Institution)
  • Charleston, South Carolina, United States
  • Boulder, Colorado, United States
  • Fort Collins, Colorado, United States 
  • Boston, Massachusetts, United States 
  • New York University, New York, United States (Institution)
  • New York, New York, United States (Private Practice)
  • University of Madison, Wisconsin, United States (Institution)
  • Be’er Ya’akov (Merhavim), Israel

Not yet recruiting:

  • University of British Columbia, Vancouver, British Columbia, Canada
  • Tel Aviv, Israel